AAAAAA
Results: 1-25/55
Authors:
SISTO SA
TAPP WN
LAMANCA JJ
LING W
KORN LR
NELSON AJ
NATELSON BH
Citation: Sa. Sisto et al., PHYSICAL-ACTIVITY BEFORE AND AFTER EXERCISE IN WOMEN WITH CHRONIC-FATIGUE-SYNDROME, QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 91(7), 1998, pp. 465-473
Authors:
FROSCH DL
SHOPTAW S
JARVIK ME
RAWSON RA
LING W
Citation: Dl. Frosch et al., INTEREST IN SMOKING CESSATION AMONG METHADONE-MAINTAINED OUTPATIENTS, Journal of addictive diseases, 17(2), 1998, pp. 9-19
Authors:
HASSON A
MARINELLICASEY P
RAWSON RA
LING W
Citation: A. Hasson et al., FACTORS INFLUENCING THE USE OF LAAM IN THE TREATMENT OF OPIATE DEPENDENCE, Journal of addictive diseases, 17(2), 1998, pp. 15-15
Authors:
RAWSON RA
MCCANN MJ
ZOGG J
FROSCH D
LING W
Citation: Ra. Rawson et al., TREATMENT DOSE AND TREATMENT OUTCOME - A PROSPECTIVE EXAMINATION, Journal of addictive diseases, 17(2), 1998, pp. 26-26
Authors:
ASHOFTEH A
LAU BSF
SETODA D
LING W
Citation: A. Ashofteh et al., IDENTIFYING METHADONE ABUSE IN PATIENTS RECEIVING LAAM, Journal of addictive diseases, 17(2), 1998, pp. 34-34
Authors:
LING W
CHARUVASTRA C
COLLINS JF
BATKI S
BROWN LS
KINTAUDI P
WESSON DR
MCNICHOLAS L
TUSEL DJ
MALKERNEKER U
RENNER JA
SANTOS E
CASADONTE P
FYE C
STINE S
WANG RIH
SEGAL D
Citation: W. Ling et al., BUPRENORPHINE MAINTENANCE TREATMENT OF OPIATE DEPENDENCE - A MULTICENTER, RANDOMIZED CLINICAL-TRIAL, Addiction, 93(4), 1998, pp. 475-486
Authors:
RAWSON RA
HASSON AL
HUBER AM
MCCANN MJ
LING W
Citation: Ra. Rawson et al., A 3-YEAR PROGRESS REPORT ON THE IMPLEMENTATION OF LAAM IN THE UNITED-STATES, Addiction, 93(4), 1998, pp. 533-540
Authors:
SIMON SL
DOMIER C
RAWSON R
LING W
Citation: Sl. Simon et al., COGNITIVE CONSEQUENCES OF METHAMPHETAMINE ABUSE ON TESTS OF FRONTAL-LOBE FUNCTION, Journal of cognitive neuroscience, 1998, pp. 64-64
Authors:
LING W
SHOPTAW S
MAJEWSKA D
Citation: W. Ling et al., BACLOFEN AS A COCAINE ANTI-CRAVING MEDICATION - A PRELIMINARY CLINICAL-STUDY, Neuropsychopharmacology, 18(5), 1998, pp. 403-404
Authors:
EVANS T
KALECHSTEIN A
FARINPOUR R
VANSLUIS N
KUCAKASCI S
CASTELLON S
SIMON S
LING W
HINKIN C
Citation: T. Evans et al., QUALITY-OF-LIFE AND NEUROPSYCHOLOGICAL FUNCTION IN STIMULANT ABUSERS, Archives of clinical neuropsychology, 13(1), 1998, pp. 55-55
Authors:
HINKIN CH
KALECHSTEIN A
VANSLUIS N
KUCUKASCI S
CASTELLON SA
SIMON S
LING W
Citation: Ch. Hinkin et al., METHAMPHETAMINE ABUSE AND REACTION-TIME DEFICITS - A PRELIMINARY-REPORT, Archives of clinical neuropsychology, 13(1), 1998, pp. 58-59
Authors:
GAN XH
ZHANG L
NEWTON T
CHANG SL
LING W
KERMANI V
BERGER O
GRAVES MC
FIALA M
Citation: Xh. Gan et al., COCAINE INFUSION INCREASES INTERFERON-GAMMA AND DECREASES INTERLEUKIN-10 IN COCAINE-DEPENDENT SUBJECTS, Clinical immunology and immunopathology (Print), 89(2), 1998, pp. 181-190
Authors:
LING W
CHUNG JN
TROUTT TR
CROWE CT
Citation: W. Ling et al., DIRECT NUMERICAL-SIMULATION OF A 3-DIMENSIONAL TEMPORAL MIXING LAYER WITH PARTICLE DISPERSION, Journal of Fluid Mechanics, 358, 1998, pp. 61-85
Authors:
HUBER A
LING W
SHOPTAW S
GULATI V
BRETHEN P
RAWSON R
Citation: A. Huber et al., INTEGRATING TREATMENTS FOR METHAMPHETAMINE ABUSE - A PSYCHOSOCIAL PERSPECTIVE, Journal of addictive diseases, 16(4), 1997, pp. 41-50
INTEGRATION OF RESEARCH IN PHARMACOTHERAPY FOR ADDICTIVE DISEASE - WHERE ARE WE - WHERE ARE WE GOING
Authors:
LING W
SHOPTAW S
Citation: W. Ling et S. Shoptaw, INTEGRATION OF RESEARCH IN PHARMACOTHERAPY FOR ADDICTIVE DISEASE - WHERE ARE WE - WHERE ARE WE GOING, Journal of addictive diseases, 16(4), 1997, pp. 83-102
Authors:
DEUTSCH CR
HUBER A
LING W
RAWSON RA
Citation: Cr. Deutsch et al., LAAM EFFECTS ON CARDIOVASCULAR FUNCTIONING, Journal of addictive diseases, 16(2), 1997, pp. 8-8
Authors:
GUDEMAN DM
CARTER WC
CHARUVASTRA VC
LING W
Citation: Dm. Gudeman et al., CLINICAL UTILITY OF SCREENING LABORATORIES IN THE INITIATION OF METHADONE TREATMENT, Journal of addictive diseases, 16(2), 1997, pp. 13-13
Authors:
GULATI V
HUBER A
BRETHEN P
RAWSON R
LING W
Citation: V. Gulati et al., METHAMPHETAMINE CRISIS IN CALIFORNIA - CHARACTERISTICS OF USERS AND TREATMENT OUTCOMES, Journal of addictive diseases, 16(2), 1997, pp. 14-14
Authors:
LING D
HUBER A
LING W
CHARUVASTRA VC
Citation: D. Ling et al., BUPRENORPHINE NALOXONE COMBINATION TABLET - CONTINUATION STUDY OUTCOMES/, Journal of addictive diseases, 16(2), 1997, pp. 21-21
Authors:
MCCANN MJ
RAWSON RA
MIOTTO K
SHOPTAW SJ
OBERT JL
LING W
Citation: Mj. Mccann et al., OPIOID DEPENDENCE TREATMENT WITH NALTREXONE - VALUE OF A MANUALIZED PSYCHOSOCIAL PROTOCOL, Journal of addictive diseases, 16(2), 1997, pp. 28-28
Authors:
NAHOM D
SHOPTAW S
CHARUVASTRA VC
AJIR K
LING W
Citation: D. Nahom et al., METHADONE DOSE EFFECTS ON TREATMENT EFFICACY, Journal of addictive diseases, 16(2), 1997, pp. 30-30
Authors:
ZOGG J
MCCANN MJ
RAWSON RA
LING W
Citation: J. Zogg et al., SUBSTANCE-ABUSE TREATMENT OUTCOMES AND PROGRAM DURATION, Journal of addictive diseases, 16(2), 1997, pp. 39-39
Authors:
MCCANN MJ
MIOTTO K
RAWSON RA
HUBER A
SHOPTAW S
LING W
Citation: Mj. Mccann et al., OUTPATIENT NONOPIOID DETOXIFICATION FOR OPIOID WITHDRAWAL - WHO IS LIKELY TO BENEFIT, The American journal on addictions, 6(3), 1997, pp. 218-223
Authors:
SHOPTAW S
FROSCH D
RAWSON RA
LING W
Citation: S. Shoptaw et al., COCAINE ABUSE COUNSELING AS HIV PREVENTION, AIDS education and prevention, 9(6), 1997, pp. 511-520
Authors:
FROSCH D
RAWSON R
PORTNOFF M
SHOPTAW S
LING W
Citation: D. Frosch et al., ETHNIC-DIFFERENCES AMONG COUNSELORS WHO TREAT SUBSTANCE-ABUSERS WITH HIV, Journal of psychopathology and behavioral assessment, 19(2), 1997, pp. 187-188